港股異動 | 東方海外國際(0316.HK)漲幅擴大至16% 將派發特別股息
格隆匯12月9日丨東方海外國際(0316.HK)今日跳空高開,午後漲幅進一步擴大至16.4%,報55港元,暫成交1291萬港元,最新總市值344.2億港元。值得注意的是,此前公司股價交易十分低迷,活躍度稍顯不足。東方海外國際日前公告,董事會宣佈於2020年2月3日向於2019年12月27日名列公司股東名冊公司股東派發特別股息,每股普通股1.6美元(12.48港元,乃按1美元兑7.8港元匯率折算)(特別股息)。此前,截至2019年9月30日止第三季度的總貨運量較去年同期上升4.1%,總收益增加5.8%,報16.46億美元。每個標準箱的整體平均收益較去年第三季增加1.6%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.